Sun Pharmaceutical Industries has launched the website for its long-term care (LTC) division, www.sunltc.com, in the US market. The new website presents the company’s LTC portfolio of alternative formulation products and underscores Sun Pharma’s commitment to meeting the needs of the up to 40% of American adults who cannot or will not swallow solid medication forms.
The company’s LTC portfolio includes the first and only US Food and Drug Administration (USFDA)- approved extended-release sprinkle formulation of metoprolol succinate; the first and only FDA approved sprinkle formulation of delayed-release duloxetine; and the first and only approved sprinkle formulation of rosuvastatin, Ezallor Sprinkle (rosuvastatin) immediate-release capsules. The Ezallor Sprinkle label was recently updated to allow for sprinkling the capsule contents over pudding (in addition to applesauce) as a soft-food alternative mode of administration.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |